Cahaba Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Cahaba Wealth Management's AMGN Position: Q1 2026 in Review
Cahaba Wealth Management reduced its Amgen (AMGN) stake by 9.6% in Q1 2026, selling an estimated $24.2K and leaving 637 shares worth $224K. The position accounts for 0.02% of the portfolio, ranked #142.
Cahaba Wealth Management first reported a position in AMGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $531K in Q4 2021. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Cahaba Wealth Management held 637 shares of Amgen worth $224K as of Q1 2026.
- Cahaba Wealth Management sold 68 Amgen shares in Q1 2026, an estimated $24.2K.
- Amgen made up 0.02% of Cahaba Wealth Management's portfolio in Q1 2026, its #142 holding.
- Cahaba Wealth Management first reported a position in Amgen in Q3 2021 and has held it in 19 quarters since.
- Cahaba Wealth Management's Amgen position peaked at $531K in Q4 2021.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Cahaba Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.